Mumps Vaccines: Current Challenges and Future Prospects
Frontiers in Microbiology, 2020 Five decades have passed since the first mumps vaccine was licensed. Over this period, a resurgence of mumps infections has been recorded worldwide. Although global mumps infections have been controlled through vaccination, outbreaks are still on the ...
Iman Almansour
doaj +2 more sources
Journal of Epidemiology, 2021 Background: Mumps vaccination coverage is low in Japan, partly because of its voluntary nature. Although pediatric cases of mumps virus infection are captured by the National Epidemiological Surveillance of Infectious Diseases program under the ...
Satoko Ohfuji +5 more
doaj +2 more sources
Molecular characterization of mumps viruses from the 2022–2023 outbreak reveals circulation of multiple genotypes in Uganda [PDF]
Virology JournalMumps is a highly contagious viral disease caused by the mumps virus (MuV), a member of the genus Orthorubulavirus in the family Paramyxoviridae. Although effective vaccines exist, mumps vaccination is not yet part of Uganda’s routine immunization ...
Phionah Tushabe +12 more
doaj +2 more sources
Trend dynamics of mumps prevalence among children aged 1–9 years in Changzhou, 2005–2023: a joinpoint regression and age-period-cohort analysis [PDF]
BMC Public HealthBackground Despite the inclusion of one dose of measles-mumps-rubella (MMR) vaccination in the Expanded Programme on Immunization (EPI), mumps cases and outbreaks continue to occur.
Dan Wu +10 more
doaj +2 more sources
Epidemiology of mumps, mumps complications, and mumps orchitis in Korea using the National Health Insurance Service database [PDF]
Investigative and Clinical Urology, 2023 Purpose: To analyze the presentation of mumps and mumps orchitis using the National Health Insurance Service Database (NHISD). Materials and Methods: Using information from the NHISD representing all cases of mumps in Korea, data regarding mumps ...
Jung Wan Yoo +6 more
doaj +1 more source
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study [PDF]
Scripta Medica, 2021 Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP).
Gupta Riya, Saxena Naveen, Gupta Parul
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2022 Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule.
Dong Li +8 more
doaj +1 more source
Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
Journal of Epidemiology, 2022 Background: Mumps deafness causes serious problems, and incidence data are needed to identify its disease burden. However, such data are limited, and the reported incidence is highly variable.
Akira Takagi +5 more
doaj +1 more source
Epidemics, 2022 Recent mumps outbreaks among highly vaccinated populations, including college students, have called into question the vaccine effectiveness (VE) of routine two-dose measles, mumps, and rubella (MMR2) immunization. We aimed to estimate the VE required for
Michael Melgar +2 more
doaj +1 more source
Upward Trends of Parotitis and Mumps in Atlanta over a Decade
Global Pediatric Health, 2020 Rising rates of mumps in Georgia have been reported. We hypothesize that the incidence of parotitis and mumps presenting to Children’s Healthcare of Atlanta (CHOA) has increased over the past decade among immunized children.
Lankala M. Reddy MD +9 more
doaj +1 more source